marketcaparena
Search

    AQST

    Aquestive Therapeutics, Inc.

    Company overview

    Market capitalization
    $596.18M
    Employees
    147
    Latest publication
    2026-09-29
    About Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue13,819,000USD14,446,000USD13,015,000USD12,807,000USD10,003,000USD8,720,000USD11,867,000USD13,542,000USD
    Cost Of Revenue4,017,000USD3,469,000USD5,836,000USD4,506,000USD4,561,000USD3,652,000USD4,520,000USD4,437,000USD
    Gross Profit9,802,000USD10,977,000USD7,179,000USD8,301,000USD5,442,000USD5,068,000USD7,347,000USD9,105,000USD
    Research Development3,962,000USD4,204,000USD3,196,000USD4,530,000USD4,105,000USD5,361,000USD4,917,000USD5,269,000USD
    Selling General Administrative14,063,000USD10,977,000USD32,822,000USD15,250,000USD12,705,000USD19,072,000USD16,009,000USD12,126,000USD
    Total Operating Expenses18,025,000USD15,181,000USD36,018,000USD19,780,000USD16,810,000USD24,433,000USD20,926,000USD17,395,000USD
    Operating Income-8,223,000USD-4,204,000USD-28,839,000USD-11,479,000USD-11,368,000USD-19,365,000USD-13,579,000USD-8,290,000USD
    Total Other Income Expense Net-14,641,000USD-3,853,000USD-3,021,000USD-3,967,000USD-2,180,000USD-3,565,000USD-3,490,000USD-3,219,000USD
    Interest Expense2,807,000USD3,936,000USD4,273,000USD4,273,000USD4,276,000USD4,278,000USD4,224,000USD4,198,000USD
    Income Before Tax-22,864,000USD-8,057,000USD-31,860,000USD-15,446,000USD-13,548,000USD-22,930,000USD-17,069,000USD-11,509,000USD
    Income Tax Expense0USD—————-14,000USD—
    Net Income-22,864,000USD-8,057,000USD-31,860,000USD-15,446,000USD-13,548,000USD-22,930,000USD-17,055,000USD-11,509,000USD
    Interest Income—83,000USD1,252,000USD306,000USD2,096,000USD713,000USD734,000USD979,000USD
    Net Interest Income—-3,853,000USD-3,021,000USD-3,967,000USD-2,180,000USD-3,565,000USD-3,490,000USD-3,219,000USD
    Net Income From Continuing Ops—-8,057,000USD-31,860,000USD-15,446,000USD-13,548,000USD-22,930,000USD-17,055,000USD-11,509,000USD
    Ebit—-4,204,000USD-28,839,000USD-11,479,000USD-11,368,000USD-19,365,000USD-12,845,000USD-7,311,000USD
    Ebitda—-4,085,000USD-28,709,000USD-11,340,000USD-11,228,000USD-19,226,000USD-12,698,000USD-7,152,000USD
    Depreciation And Amortization—119,000USD130,000USD139,000USD140,000USD139,000USD147,000USD159,000USD
    Reconciled Depreciation—113,000USD130,000USD139,000USD140,000USD139,000USD147,000USD159,000USD
    Tax Provision——————-14,000USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue44,545,000USD57,561,000USD50,583,000USD47,680,000USD50,832,000USD45,849,000USD52,609,000USD67,430,000USD
    Cost Of Revenue17,154,279USD17,872,000USD20,831,000USD19,386,000USD14,989,000USD12,964,000USD20,361,000USD20,988,000USD
    Gross Profit27,390,721USD39,689,000USD29,752,000USD28,294,000USD35,843,000USD32,885,000USD32,248,000USD46,442,000USD
    Research Development17,192,000USD20,280,000USD13,104,000USD17,481,000USD17,047,000USD19,886,000USD20,574,000USD23,112,000USD
    Selling General Administrative79,849,000USD50,180,000USD31,750,000USD52,879,000USD53,475,000USD55,892,000USD64,342,000USD72,264,000USD
    Total Operating Expenses97,041,000USD70,460,000USD44,854,000USD70,360,000USD70,522,000USD75,778,000USD84,916,000USD95,376,000USD
    Operating Income-69,650,279USD-30,771,000USD-15,102,000USD-42,066,000USD-34,679,000USD-42,893,000USD-52,668,000USD-48,934,000USD
    Interest Income4,367,000USD3,437,000USD16,321,000USD99,000USD423,000USD132,000USD636,000USD552,000USD
    Interest Expense17,100,000USD16,817,000USD7,462,000USD12,443,000USD22,461,000USD13,022,000USD9,318,000USD7,711,000USD
    Net Interest Income-12,733,000USD-13,380,000USD8,859,000USD-12,344,000USD-22,038,000USD-12,890,000USD-8,682,000USD-7,159,000USD
    Income Before Tax-83,784,000USD-44,151,000USD-7,625,000USD-54,410,000USD-70,539,000USD-55,783,000USD-66,246,000USD-61,376,000USD
    Tax Provision0USD-14,000USD245,000USD284,000USD0USD0USD0USD0USD
    Net Income-83,784,000USD-44,137,000USD-7,870,000USD-54,410,000USD-70,539,000USD-55,783,000USD-66,246,000USD-61,376,000USD
    Net Income From Continuing Ops-83,784,000USD-44,137,000USD-7,870,000USD-54,410,000USD-70,539,000USD-55,783,000USD-66,246,000USD-61,376,000USD
    Ebit-69,650,279USD-27,334,000USD-163,000USD-41,967,000USD-48,078,000USD-42,761,000USD-56,928,000USD-53,665,000USD
    Ebitda-69,091,279USD-26,616,000USD1,182,000USD-39,580,000USD-45,114,000USD-39,153,000USD-53,879,000USD-50,326,000USD
    Depreciation And Amortization559,000USD718,000USD1,345,000USD2,387,000USD2,964,000USD3,608,000USD3,049,000USD3,339,000USD
    Reconciled Depreciation548,000USD718,000USD1,345,000USD2,387,000USD2,964,000USD3,443,000USD2,905,000USD3,236,000USD
    Total Other Income Expense Net-14,133,721USD-13,380,000USD7,477,000USD-12,344,000USD-35,860,000USD-12,890,000USD-13,578,000USD-12,442,000USD
    Income Tax Expense—-14,000USD245,000USD5,792,000USD19,497,000USD9,579,000USD6,413,000USD-4,731,000USD
    Net Income Applicable To Common Shares———-54,410,000USD-70,539,000USD-55,783,000USD-66,246,000USD-61,376,000USD
    Non Operating Income Net Other————-13,399,000USD132,000USD-4,260,000USD-4,731,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets132,104,000USD141,125,000USD160,425,000USD163,559,000USD93,698,000USD102,234,000USD101,424,000USD109,958,000USD
    Cash And Equivalents98,490,000USD———————
    Total Current Assets118,494,000USD130,183,000USD149,269,000USD151,673,000USD81,721,000USD89,169,000USD88,220,000USD96,570,000USD
    Other Current Assets3,312,000USD4,516,000USD4,168,000USD2,925,000USD1,196,000USD2,870,000USD3,286,000USD1,972,000USD
    Other Non Current Assets1,701,000USD———————
    Total Liabilities188,690,000USD———————
    Total Current Liabilities16,478,000USD31,753,000USD47,608,000USD25,574,000USD23,155,000USD18,298,000USD18,865,000USD15,152,000USD
    Other Current Liabilities4,518,000USD———————
    Other Non Current Liabilities6,185,000USD———————
    Total Stockholder Equity-56,586,000USD-34,054,000USD-33,662,000USD-4,109,000USD-72,590,000USD-60,930,000USD-60,156,000USD-45,420,000USD
    Total Equity Including Noncontrolling Interest-56,586,000USD———————
    Long Term Debt50,654,000USD25,099,000USD27,519,000USD29,940,000USD31,843,000USD33,746,000USD32,500,000USD31,253,000USD
    Deferred Revenue1,092,000USD———————
    Deferred Revenue Non Current18,845,000USD———————
    Inventory7,366,000USD8,066,000USD6,169,000USD7,884,000USD8,125,000USD7,198,000USD6,044,000USD7,021,000USD
    Property Plant Equipment Net11,909,000USD8,307,000USD8,514,000USD8,687,000USD8,769,000USD8,850,000USD8,981,000USD9,158,000USD
    Accounts Payable8,965,000USD11,889,000USD29,862,000USD10,865,000USD11,951,000USD12,280,000USD10,287,000USD7,572,000USD
    Short Term Debt32,000USD15,323,000USD11,625,000USD8,489,000USD3,747,000USD567,000USD536,000USD507,000USD
    Common Stock126,000USD124,000USD122,000USD121,000USD99,000USD99,000USD91,000USD91,000USD
    Retained Earnings-477,919,000USD-455,055,000USD-446,998,000USD-415,138,000USD-399,692,000USD-386,144,000USD-363,214,000USD-346,159,000USD
    Total Liab—175,179,000USD194,087,000USD167,668,000USD166,288,000USD163,164,000USD161,580,000USD155,378,000USD
    Other Current Liab—3,449,000USD5,029,000USD5,128,000USD6,029,000USD3,986,000USD6,629,000USD5,552,000USD
    Capital Stock—124,000USD122,000USD121,000USD99,000USD99,000USD91,000USD91,000USD
    Cash—110,734,000USD121,169,000USD129,062,999USD60,536,000USD68,657,000USD71,546,000USD77,893,000USD
    Cash And Short Term Investments—110,734,000USD121,169,000USD129,062,999USD60,536,000USD68,657,000USD71,546,000USD77,893,000USD
    Current Deferred Revenue—1,092,000USD1,092,000USD1,092,000USD1,092,000USD1,048,000USD1,048,000USD1,048,000USD
    Net Debt—22,844,000USD10,276,000USD-200,999USD-20,278,000USD-29,522,000USD-33,542,000USD-41,024,000USD
    Short Long Term Debt—13,661,000USD9,994,000USD6,327,000USD3,177,000USD27,000USD26,000USD25,000USD
    Short Long Term Debt Total—133,578,000USD131,445,000USD128,862,000USD40,258,000USD39,135,000USD38,004,000USD36,869,000USD
    Net Receivables—6,867,000USD17,763,000USD11,801,000USD11,864,000USD10,444,000USD7,344,000USD9,684,000USD
    Property Plant Equipment Gross—52,434,000USD52,535,000USD52,586,000USD52,536,000USD52,484,000USD52,482,000USD52,516,000USD
    Common Stock Shares Outstanding—122,609,995shares121,966,911shares110,584,371shares99,326,701shares95,497,056shares91,199,407shares91,082,081shares
    Non Current Assets Total—10,942,000USD11,156,000USD11,885,999USD11,977,000USD13,065,000USD13,204,000USD13,388,000USD
    Non Current Liabilities Total—143,426,000USD146,479,000USD142,094,000USD143,133,000USD144,866,000USD142,715,000USD140,226,000USD
    Non Current Liabilities Other—32,967,000USD33,210,000USD26,006,000USD24,763,000USD23,777,000USD22,524,000USD20,868,000USD
    Non Currrent Assets Other—635,000USD642,000USD1,198,999USD3,208,000USD1,215,000USD1,223,000USD1,230,000USD
    Net Working Capital—98,430,000USD101,661,000USD126,099,000USD58,566,000USD70,871,000USD69,355,000USD81,418,000USD
    Unclassified Non Current Assets—2,000,000USD2,000,000USD2,000,000USD—3,000,000USD3,000,000USD3,000,000USD
    Unclassified Current Liabilities—-13,661,000USD-9,994,000USD-6,327,000USD-2,841,000USD———
    Unclassified Non Current Liabilities—85,360,000USD85,750,000USD86,148,000USD86,527,000USD87,343,000USD87,691,000USD88,105,000USD
    Unclassified Equity—420,753,000USD413,092,000USD410,787,000USD326,904,000USD325,016,000USD302,876,000USD300,557,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets160,425,000USD101,424,000USD57,418,000USD57,070,000USD61,993,000USD62,884,000USD78,479,000USD86,851,000USD
    Other Current Assets4,168,000USD3,286,000USD1,854,000USD2,131,000USD3,077,000USD3,402,000USD2,999,000USD3,360,000USD
    Total Liab194,087,000USD161,580,000USD163,905,000USD175,624,000USD144,127,000USD111,381,000USD84,601,000USD76,771,000USD
    Total Stockholder Equity-33,662,000USD-60,156,000USD-106,487,000USD-118,554,000USD-82,134,000USD-48,497,000USD-6,122,000USD10,080,000USD
    Other Current Liab5,029,000USD6,629,000USD7,082,000USD8,792,000USD9,612,000USD9,703,000USD5,175,000USD4,292,000USD
    Common Stock122,000USD91,000USD69,000USD55,000USD41,000USD35,000USD34,000USD25,000USD
    Capital Stock122,000USD91,000USD69,000USD55,000USD41,000USD35,000USD34,000USD25,000USD
    Retained Earnings-446,998,000USD-363,214,000USD-319,077,000USD-311,207,000USD-256,796,000USD-186,257,000USD-130,474,000USD-61,376,000USD
    Cash121,169,000USD71,546,000USD23,872,000USD27,273,000USD28,024,000USD31,807,000USD49,326,000USD60,599,000USD
    Cash And Short Term Investments121,169,000USD71,546,000USD23,872,000USD27,273,000USD28,024,000USD31,807,000USD49,326,000USD60,599,000USD
    Total Current Assets149,269,000USD88,220,000USD40,966,000USD39,888,000USD47,259,000USD44,625,000USD68,314,000USD74,201,000USD
    Total Current Liabilities47,608,000USD18,865,000USD18,308,000USD39,528,000USD21,964,000USD21,104,000USD18,555,000USD32,952,000USD
    Current Deferred Revenue1,092,000USD1,048,000USD1,551,000USD1,513,000USD765,000USD693,000USD806,000USD721,000USD
    Net Debt10,276,000USD-33,542,000USD9,447,000USD30,215,000USD28,397,000USD8,671,000USD11,012,000USD-13,396,000USD
    Short Term Debt11,625,000USD536,000USD412,000USD18,955,000USD2,924,000USD3,303,000USD—4,600,000USD
    Short Long Term Debt9,994,000USD26,000USD22,000USD18,700,000USD2,025,000USD2,575,000USD—4,600,000USD
    Short Long Term Debt Total131,445,000USD38,004,000USD33,319,000USD57,488,000USD56,421,000USD40,478,000USD60,338,000USD47,203,000USD
    Long Term Debt27,519,000USD32,500,000USD27,508,000USD33,448,000USD51,551,000USD34,329,000USD60,338,000USD42,603,000USD
    Net Receivables17,763,000USD7,344,000USD8,471,000USD4,704,000USD12,120,000USD6,955,000USD13,130,000USD6,481,000USD
    Inventory6,169,000USD6,044,000USD6,769,000USD5,780,000USD4,038,000USD2,461,000USD2,859,000USD5,441,000USD
    Accounts Payable29,862,000USD10,287,000USD8,926,000USD9,946,000USD8,314,000USD7,089,000USD12,274,000USD20,436,000USD
    Property Plant Equipment Net8,514,000USD8,981,000USD9,736,000USD9,296,000USD7,780,000USD10,321,000USD9,726,000USD12,207,000USD
    Property Plant Equipment Gross52,535,000USD52,482,000USD52,620,000USD7,901,000USD7,780,000USD10,321,000USD9,726,000USD12,207,000USD
    Common Stock Shares Outstanding121,966,911shares86,726,211shares61,255,864shares48,734,377shares38,077,660shares33,651,127shares25,356,098shares20,725,526shares
    Non Current Assets Total11,156,000USD13,204,000USD16,452,000USD17,182,000USD14,734,000USD18,259,000USD10,165,000USD12,650,000USD
    Non Current Liabilities Total146,479,000USD142,715,000USD145,597,000USD136,096,000USD122,163,000USD90,277,000USD66,046,000USD43,819,000USD
    Non Current Liabilities Other33,210,000USD22,524,000USD16,777,000USD2,034,000USD61,005,000USD1,945,000USD——
    Non Currrent Assets Other642,000USD1,223,000USD1,438,000USD6,451,000USD6,903,000USD7,836,000USD286,000USD239,000USD
    Net Working Capital101,661,000USD69,355,000USD22,658,000USD209,000USD25,295,000USD23,521,000USD49,759,000USD41,249,000USD
    Unclassified Non Current Assets2,000,000USD3,000,000USD3,999,999USD-6,451,000USD-6,903,000USD-7,836,000USD——
    Unclassified Current Liabilities-9,994,000USD——-18,378,000USD-1,676,000USD-2,259,000USD—-1,697,000USD
    Unclassified Non Current Liabilities85,750,000USD87,691,000USD101,312,000USD3,051,000USD-59,059,000USD———
    Unclassified Equity413,092,000USD302,876,000USD212,452,000USD192,543,000USD174,580,000USD137,690,000USD162,328,000USD106,597,000USD
    Intangible Assets——1,278,000USD1,435,000USD51,000USD102,000USD153,000USD204,000USD
    Other Assets——1USD6,451,000USD6,903,000USD7,836,000USD286,000USD239,000USD
    Other Liab———97,563,000USD68,666,000USD53,102,000USD5,708,000USD1,216,000USD
    Net Tangible Assets———-119,989,000USD-82,185,000USD-48,599,000USD-6,275,000USD9,876,000USD
    Good Will——————286,000USD—
    Accumulated Other Comprehensive Income——————-38,044,000USD-35,191,000USD
    Unclassified Current Assets———————-1,680,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,057,000USD-31,860,000USD-15,446,000USD-13,548,000USD-22,930,000USD-17,055,000USD-11,509,000USD-2,745,000USD
    Depreciation119,000USD130,000USD139,000USD140,000USD139,000USD147,000USD159,000USD205,000USD
    Stock Based Compensation2,318,000USD1,376,000USD2,777,000USD1,884,000USD1,587,000USD2,403,000USD1,577,000USD1,539,000USD
    Other Non Cash Items5,520,000USD2,750,000USD2,759,000USD2,691,000USD2,796,000USD2,732,000USD2,725,000USD2,356,000USD
    Change To Account Receivables10,896,000USD-5,959,000USD63,000USD-1,347,000USD-3,129,000USD2,322,000USD-2,486,000USD2,339,000USD
    Change To Inventory-1,896,000USD1,714,000USD241,000USD-927,000USD-1,154,000USD977,000USD-55,000USD768,000USD
    Change In Working Capital-12,388,000USD19,135,000USD-2,878,000USD919,000USD-4,992,000USD5,284,000USD-4,832,000USD-8,361,000USD
    Total Cash From Operating Activities-14,806,000USD-8,469,000USD-12,649,000USD-7,914,000USD-23,400,000USD-6,489,000USD-11,880,000USD-7,006,000USD
    Capital Expenditures-52,000USD-85,000USD-235,000USD-107,000USD-135,000USD-15,000USD-80,000USD-35,000USD
    Free Cash Flow-14,858,000USD-8,554,000USD-12,884,000USD-8,021,000USD-23,535,000USD-6,504,000USD-11,960,000USD-7,041,000USD
    Total Cashflows From Investing Activities-52,000USD-85,000USD-235,000USD-107,000USD-135,000USD-15,000USD-80,000USD-35,000USD
    Net Borrowings-8,000USD-5,000USD-7,000USD-8,000USD-6,000USD-5,000USD-8,000USD—
    Total Cash From Financing Activities4,423,000USD660,000USD81,411,000USD-100,000USD20,646,000USD157,000USD-17,000USD1,711,000USD
    Issuance Of Capital Stock4,759,000USD-301,000USD79,719,000USD-124,000USD21,360,000USD-34,000USD0USD1,691,000USD
    Change In Cash-10,435,000USD-7,894,000USD68,527,000USD-8,121,000USD-2,889,000USD-6,347,000USD-11,977,000USD-5,330,000USD
    Begin Period Cash Flow121,169,000USD129,063,000USD60,536,000USD68,657,000USD71,546,000USD77,893,000USD89,870,000USD95,200,000USD
    End Period Cash Flow110,734,000USD121,169,000USD129,063,000USD60,536,000USD68,657,000USD71,546,000USD77,893,000USD89,870,000USD
    Other Cashflows From Financing Activities-329,000USD-18,000USD1,699,000USD32,000USD-703,000USD196,000USD-202,000USD25,000USD
    Unclassified Operating Cash Flow-2,318,000USD———————
    Investments——-235,000USD-107,000USD-135,000USD-15,000USD-80,000USD-35,000USD
    Sale Purchase Of Stock——————898,000USD-5,000USD
    Other Cashflows From Investing Activities———————-35,000USD
    Unclassified Financing Cash Flow———————1,691,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-83,784,000USD-44,137,000USD-7,870,000USD-54,410,000USD-70,539,000USD-55,783,000USD-66,246,000USD-61,376,000USD
    Depreciation548,000USD718,000USD1,345,000USD2,387,000USD2,964,000USD3,443,000USD2,905,000USD3,236,000USD
    Stock Based Compensation7,624,000USD7,099,000USD2,689,000USD4,381,000USD6,819,000USD6,581,000USD7,071,000USD29,940,000USD
    Other Non Cash Items10,996,000USD10,518,000USD2,797,000USD5,846,000USD29,507,000USD4,713,000USD7,184,000USD1,930,000USD
    Change To Account Receivables-10,372,000USD1,094,000USD-3,073,000USD7,352,000USD-5,353,000USD1,202,000USD-6,815,000USD-409,000USD
    Change To Inventory-126,000USD725,000USD-989,000USD-1,743,000USD-1,577,000USD398,000USD2,582,000USD-1,427,000USD
    Change In Working Capital12,184,000USD-9,957,000USD-5,341,000USD32,007,000USD-1,730,000USD-4,413,000USD-11,124,000USD7,998,000USD
    Total Cash From Operating Activities-52,432,000USD-35,759,000USD-6,380,000USD-9,789,000USD-32,979,000USD-45,459,000USD-60,210,000USD-12,991,000USD
    Capital Expenditures-562,000USD-159,000USD-995,000USD-2,524,000USD-913,000USD-517,000USD-663,000USD-1,824,000USD
    Free Cash Flow-52,994,000USD-35,918,000USD-7,375,000USD-12,313,000USD-33,892,000USD-45,976,000USD-60,873,000USD-14,815,000USD
    Total Cashflows From Investing Activities-562,000USD-159,000USD-995,000USD-2,524,000USD-913,000USD-517,000USD-663,000USD-1,824,000USD
    Net Borrowings-26,000USD-23,000USD-22,487,000USD-2,025,000USD0USD22,341,000USD13,110,000USD-4,768,000USD
    Total Cash From Financing Activities102,617,000USD83,592,000USD3,974,000USD11,562,000USD30,109,000USD28,457,000USD49,600,000USD58,035,000USD
    Issuance Of Capital Stock100,654,000USD83,757,000USD8,912,000USD13,556,000USD29,780,000USD6,215,000USD39,317,000USD68,714,000USD
    Change In Cash49,623,000USD47,674,000USD-3,401,000USD-751,000USD-3,783,000USD-17,519,000USD-11,273,000USD43,220,000USD
    Begin Period Cash Flow71,546,000USD23,872,000USD27,273,000USD28,024,000USD31,807,000USD49,326,000USD60,599,000USD17,379,000USD
    End Period Cash Flow121,169,000USD71,546,000USD23,872,000USD27,273,000USD28,024,000USD31,807,000USD49,326,000USD60,599,000USD
    Other Cashflows From Financing Activities-810,000USD-142,000USD15,447,000USD1,000USD329,000USD44,742,000USD-6,773,000USD-10,795,000USD
    Unclassified Financing Cash Flow2,799,000USD—11,025,000USD13,592,000USD29,794,000USD-38,428,000USD48,917,000USD4,768,000USD
    Investments—-159,000USD-995,000USD-2,524,000USD-913,000USD-517,000USD-663,000USD-1,824,000USD
    Sale Purchase Of Stock——-11,000USD-3,000USD-14,000USD-99,000USD-2,827,000USD68,830,000USD
    Change To Liabilities———1,633,000USD3,942,000USD-3,033,000USD-5,525,000USD10,974,000USD
    Dividends Paid———-3,000USD—-99,000USD-2,827,000USD—
    Other Cashflows From Investing Activities———-1,500,000USD————
    Unclassified Investing Cash Flow———4,024,000USD———1,824,000USD
    Cash And Cash Equivalents Changes————-3,783,000USD-17,519,000USD-11,273,000USD43,220,000USD
    Unclassified Operating Cash Flow———————5,281,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyInternational1,201,000USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31GeographyUnited States13,245,000USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31ProductCo Development And Research Fees258,000USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31ProductLicense And Royalty Revenue5,395,000USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31ProductManufacture And Supply Revenue8,793,000USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31ProductProprietary Product Revenue0USD0001398733-26-000030
    Q1 2026Quarterly · 2026-03-31ProductRoyalty0USD0001398733-26-000030
    Q4 2025Quarterly · 2025-12-31GeographyInternational3,626,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States9,389,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational14,941,000USD0001398733-26-000018
    FY 2025Yearly · 2025-12-31GeographyUnited States29,604,000USD0001398733-26-000018
    Q3 2025Quarterly · 2025-09-30GeographyInternational2,684,000USD0001398733-25-000028
    Q3 2025Quarterly · 2025-09-30GeographyUnited States10,123,000USD0001398733-25-000028
    Q3 2025Quarterly · 2025-09-30ProductCo Development And Research Fees302,000USD0001398733-25-000028
    Q3 2025Quarterly · 2025-09-30ProductLicense And Royalty Revenue1,038,000USD0001398733-25-000028
    Q3 2025Quarterly · 2025-09-30ProductManufacture And Supply Revenue11,467,000USD0001398733-25-000028
    Q3 2025Quarterly · 2025-09-30ProductManufactured Product Other0USD0001398733-25-000028
    Q2 2025Quarterly · 2025-06-30GeographyInternational5,112,000USD0001398733-25-000013
    Q2 2025Quarterly · 2025-06-30GeographyUnited States4,891,000USD0001398733-25-000013
    Q2 2025Quarterly · 2025-06-30ProductCo Development And Research Fees378,000USD0001398733-25-000013
    Q2 2025Quarterly · 2025-06-30ProductLicense And Royalty Revenue839,000USD0001398733-25-000013
    Q2 2025Quarterly · 2025-06-30ProductManufacture And Supply Revenue9,583,000USD0001398733-25-000013
    Q2 2025Quarterly · 2025-06-30ProductManufactured Product Other-797,000USD0001398733-25-000013
    Q1 2025Quarterly · 2025-03-31GeographyInternational3,519,000USD0001398733-26-000030
    Q1 2025Quarterly · 2025-03-31GeographyUnited States5,201,000USD0001398733-26-000030
    Q1 2025Quarterly · 2025-03-31ProductCo Development And Research Fees418,000USD0001628280-25-024664
    Q1 2025Quarterly · 2025-03-31ProductLicense And Royalty Revenue790,000USD0001628280-25-024664
    Q1 2025Quarterly · 2025-03-31ProductManufacture And Supply Revenue7,193,000USD0001628280-25-024664
    Q1 2025Quarterly · 2025-03-31ProductManufactured Product Other319,000USD0001628280-25-024664
    Q1 2025Quarterly · 2025-03-31ProductRoyalty0USD0001628280-25-024664
    Q4 2024Quarterly · 2024-12-31GeographyInternational2,535,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States9,332,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational17,631,000USD0001398733-26-000018
    FY 2024Yearly · 2024-12-31GeographyUnited States39,930,000USD0001398733-26-000018
    Q3 2024Quarterly · 2024-09-30GeographyInternational3,014,000USD0001398733-25-000028
    Q3 2024Quarterly · 2024-09-30GeographyUnited States10,528,000USD0001398733-25-000028
    Q3 2024Quarterly · 2024-09-30ProductCo Development And Research Fees492,000USD0001398733-25-000028
    Q3 2024Quarterly · 2024-09-30ProductLicense And Royalty Revenue2,162,000USD0001398733-25-000028
    Q3 2024Quarterly · 2024-09-30ProductManufacture And Supply Revenue10,671,000USD0001398733-25-000028
    Q3 2024Quarterly · 2024-09-30ProductManufactured Product Other217,000USD0001398733-25-000028
    Q2 2024Quarterly · 2024-06-30GeographyInternational10,456,000USD0001398733-25-000013
    Q2 2024Quarterly · 2024-06-30GeographyUnited States9,643,000USD0001398733-25-000013
    Q2 2024Quarterly · 2024-06-30ProductCo Development And Research Fees756,000USD0001398733-25-000013
    Q2 2024Quarterly · 2024-06-30ProductLicense And Royalty Revenue11,220,000USD0001398733-25-000013
    Q2 2024Quarterly · 2024-06-30ProductManufacture And Supply Revenue8,123,000USD0001398733-25-000013
    Q2 2024Quarterly · 2024-06-30ProductManufactured Product Other0USD0001398733-25-000013
    Q1 2024Quarterly · 2024-03-31ProductCo Development And Research Fees403,000USD0001628280-25-024664
    Q1 2024Quarterly · 2024-03-31ProductLicense And Royalty Revenue1,132,000USD0001628280-25-024664
    Q1 2024Quarterly · 2024-03-31ProductManufacture And Supply Revenue10,518,000USD0001628280-25-024664
    Q1 2024Quarterly · 2024-03-31ProductManufactured Product Other0USD0001628280-25-024664
    FY 2023Yearly · 2023-12-31GeographyInternational13,479,000USD0001628280-25-010506
    FY 2023Yearly · 2023-12-31GeographyUnited States37,104,000USD0001628280-25-010506
    FY 2023Yearly · 2023-12-31ProductCo Development And Research Fees1,402,000USD0001628280-24-009010
    FY 2023Yearly · 2023-12-31ProductLicense And Royalty Revenue5,376,000USD0001628280-24-009010
    FY 2023Yearly · 2023-12-31ProductManufacture And Supply Revenue43,805,000USD0001628280-24-009010
    FY 2023Yearly · 2023-12-31ProductOther989,000USD0001628280-24-009010
    FY 2023Yearly · 2023-12-31ProductProprietary Product Sales0USD0001628280-24-009010
    FY 2023Yearly · 2023-12-31ProductRoyalty-989,000USD0001628280-24-009010
    Q3 2023Quarterly · 2023-09-30ProductCo Development And Research Fees490,000USD0001628280-24-045030
    Q3 2023Quarterly · 2023-09-30ProductLicense And Royalty Revenue1,103,000USD0001628280-24-045030
    Q3 2023Quarterly · 2023-09-30ProductManufacture And Supply Revenue11,409,000USD0001628280-24-045030
    Q3 2023Quarterly · 2023-09-30ProductManufactured Product Other0USD0001628280-24-045030
    FY 2022Yearly · 2022-12-31GeographyInternational6,888,000USD0001628280-24-009010
    FY 2022Yearly · 2022-12-31GeographyUnited States40,792,000USD0001628280-24-009010
    FY 2022Yearly · 2022-12-31ProductCo Development And Research Fees1,293,000USD0001628280-23-010180
    FY 2022Yearly · 2022-12-31ProductLicense And Royalty Revenue2,351,000USD0001628280-23-010180
    FY 2022Yearly · 2022-12-31ProductManufacture And Supply Revenue36,378,000USD0001628280-23-010180
    FY 2022Yearly · 2022-12-31ProductOther916,000USD0001628280-23-010180
    FY 2022Yearly · 2022-12-31ProductProprietary Product Sales7,658,000USD0001628280-23-010180
    FY 2022Yearly · 2022-12-31ProductRoyalty-916,000USD0001628280-23-010180
    FY 2021Yearly · 2021-12-31GeographyInternational7,972,000USD0001628280-23-010180
    FY 2021Yearly · 2021-12-31GeographyUnited States42,860,000USD0001628280-23-010180
    FY 2021Yearly · 2021-12-31ProductCo Development And Research Fees1,635,000USD0001628280-22-005393
    FY 2021Yearly · 2021-12-31ProductLicense And Royalty Revenue5,380,000USD0001628280-22-005393
    FY 2021Yearly · 2021-12-31ProductManufacture And Supply Revenue35,312,000USD0001628280-22-005393
    FY 2021Yearly · 2021-12-31ProductOther1,102,000USD0001628280-22-005393
    FY 2021Yearly · 2021-12-31ProductProprietary Product Sales8,505,000USD0001628280-22-005393
    FY 2021Yearly · 2021-12-31ProductRoyalty-1,102,000USD0001628280-22-005393
    FY 2020Yearly · 2020-12-31GeographyInternational4,893,000USD0001628280-22-005393
    FY 2020Yearly · 2020-12-31GeographyUnited States40,956,000USD0001628280-22-005393
    FY 2019Yearly · 2019-12-31GeographyInternational4,316,000USD0001140361-21-007811
    FY 2019Yearly · 2019-12-31GeographyUnited States48,293,000USD0001140361-21-007811
    FY 2019Yearly · 2019-12-31ProductCo Development And Research Fees4,042,000USD0001140361-21-007811
    FY 2019Yearly · 2019-12-31ProductLicense And Royalty Revenue6,959,000USD0001140361-21-007811
    FY 2019Yearly · 2019-12-31ProductManufacture And Supply Revenue38,739,000USD0001140361-21-007811
    FY 2019Yearly · 2019-12-31ProductProprietary Product Sales2,869,000USD0001140361-21-007811
    FY 2018Yearly · 2018-12-31GeographyInternational2,865,000USD0001140361-20-005499
    FY 2018Yearly · 2018-12-31GeographyUnited States64,565,000USD0001140361-20-005499
    FY 2018Yearly · 2018-12-31ProductCo Development And Research Fees5,184,000USD0001140361-20-005499
    FY 2018Yearly · 2018-12-31ProductLicense And Royalty Revenue24,699,000USD0001140361-20-005499
    FY 2018Yearly · 2018-12-31ProductManufacture And Supply Revenue37,319,000USD0001140361-20-005499
    FY 2018Yearly · 2018-12-31ProductProprietary Product Sales228,000USD0001140361-20-005499
    FY 2017Yearly · 2017-12-31ProductCo Development And Research Fees3,693,000USD0001140361-19-004934
    FY 2017Yearly · 2017-12-31ProductLicense And Royalty Revenue23,133,000USD0001140361-19-004934
    FY 2017Yearly · 2017-12-31ProductManufacture And Supply Revenue40,092,000USD0001140361-19-004934
    FY 2017Yearly · 2017-12-31ProductProprietary Product Sales0USD0001140361-19-004934

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.